Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
1st Source
SRCE
$2.17B
| $18.4M | 0.01% |
354,514
+19,500
| +6% | +$980K |
|
|
CARO
1052
DELISTED
Carolina Financial Corp.
CARO
| $18.3M | 0.01% |
423,481
-82,435
| -16% | -$3.25M |
|
1053
Ezcorp Inc
EZPW
$1.79B
| $18.3M | 0.01% |
2,680,328
+346,812
| +15% | +$1.99M |
|
|
IVC
1054
DELISTED
Invacare Corporation
IVC
| $18.3M | 0.01% |
2,025,669
+475,069
| +31% | +$3.99M |
|
1055
Peoples Bancorp
PEBO
$1.51B
| $18.3M | 0.01% |
526,679
+7,800
| +2% | +$255K |
|
1056
TriMas Corp
TRS
$1.41B
| $18.3M | 0.01% |
581,170
+19,470
| +3% | +$600K |
|
1057
CACI
CACI
$10.8B
| $18.1M | 0.01% |
72,600
-51,400
| -41% | -$12M |
|
1058
Evercore
EVR
$11.8B
| $18.1M | 0.01% |
242,200
+201,600
| +497% | +$15.4M |
|
1059
Sabre
SABR
$716M
| $18.1M | 0.01% |
806,015
+751,815
| +1,387% | +$16.7M |
|
|
PE
1060
DELISTED
PARSLEY ENERGY INC
PE
| $18.1M | 0.01% |
954,900
+724,500
| +314% | +$12M |
|
1061
Descartes Systems
DSGX
$6.68B
| $18M | 0.01% |
421,700
-158,000
| -27% | -$6.45M |
|
1062
NVIDIA
NVDA
$4.6T
| $18M | 0.01% |
3,061,920
-31,849,800
| -91% | -$166M |
|
1063
Mettler-Toledo International
MTD
$28.1B
| $18M | 0.01% |
+22,700
| New | +$16.4M |
|
1064
Spok Holdings
SPOK
$229M
| $17.9M | 0.01% |
1,466,884
-70,659
| -5% | -$834K |
|
1065
LifeVantage
LFVN
$80.1M
| $17.9M | 0.01% |
1,148,905
+31,470
| +3% | +$463K |
|
1066
Liberty Media Series C
FWONK
$25.5B
| $17.9M | 0.01% |
+402,006
| New | +$16.7M |
|
|
GOGL
1067
DELISTED
Golden Ocean Group
GOGL
| $17.8M | 0.01% |
3,070,737
+634,356
| +26% | +$3.64M |
|
|
LGF.A
1068
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $17.8M | 0.01% |
1,670,450
+1,018,400
| +156% | +$9.38M |
|
1069
Deckers Outdoor
DECK
$14.1B
| $17.8M | 0.01% |
+632,400
| New | +$16.8M |
|
1070
Enerpac Tool Group
EPAC
$1.86B
| $17.8M | 0.01% |
683,693
-28,307
| -4% | -$691K |
|
|
GRA
1071
DELISTED
W.R. Grace & Co.
GRA
| $17.7M | 0.01% |
253,900
-26,700
| -10% | -$1.79M |
|
1072
LendingTree
TREE
$551M
| $17.7M | 0.01% |
58,234
+1,934
| +3% | +$640K |
|
|
DCOM
1073
DELISTED
Dime Community Bancshares
DCOM
| $17.6M | 0.01% |
842,800
+155,200
| +23% | +$3.18M |
|
1074
YPF
YPF
$19.7B
| $17.6M | 0.01% |
1,517,600
+689,300
| +83% | +$6.69M |
|
1075
Argan
AGX
$6.9B
| $17.5M | 0.01% |
436,899
-223,701
| -34% | -$8.6M |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.